Shopping Cart

KBL Merger Co. IV (KBLM) Shareholders Approve CannBioRx Deal

proxy vote

KBL Merger Co. IV (KBLM) Shareholders Approve CannBioRx Deal

Nov 6, 2020 INTEL by Nicholas Alan Clayton

KBL Merger Co. IV (NASDAQ:KBLM) announced in an 8-K filing this afternoon that its shareholders approved its merger with CannBioRx Life Sciences Corp at a special meeting November 5, but also redeemed shares worth most of its trust value. A total of 816,461 shares were redeemed, removing about $9 million from its trust and leaving
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

ByNicholas Alan Clayton